Abstract
Movement disorders are conditions in which there is either a paucity or excess of movements. Classification systems are based on clinical findings, anatomy, pathology, etiology, and genetics, none of which are perfect. Classification by genetic etiology is complicated by heterogeneity, in which many genes cause the same phenotype, as well as pleiotropy, in which mutations in a single gene can result in different phenotypes. Genetic counseling for movement disorders is also complicated by having both Mendelian and multifactorial causes of disease. This section reviews the different types of movement disorders and the issues for genetic counseling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fahn, S. (2011). Classification of movement disorders. Movement Disorders, 26(6), 947–957.
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., et al. (1998). Pathologic and biochemical studies of juvenile Parkinsonism linked to chromosome 6q. Neurology, 51(3), 890–892.
Roxburgh, R. H., Marquis-Nicholson, R., Ashton, F., George, A. M., Lea, R. A., Eccles, D., et al. (2012). The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry. Journal of Neurology, 260, 1286–1294. epublished Dec 27 2012.
Risch, N. J., Bressman, S. B., de Leon, D., Brin, M. F., Burke, R. E., Greene, P. E., et al. (1990). Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. American Journal of Human Genetics, 46, 533–538.
Sidransky, E., et al. (2009). Multicenter analysis of glucocerebrosidase mutations in Parkinson disease. The New England Journal of Medicine, 361(17), 1651–1661.
Elden, A. C., Kim, H. J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., et al. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466(7310), 1069–1075.
Grabowski, M., Zimprich, A., Lorenz-Depiereux, B., Kalscheuer, V., Asmus, F., Gasser, T., et al. (2003). The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. European Journal of Human Genetics, 11(2), 138–144.
Furukawa, Y., Lang, A. E., Trugman, J. M., Bird, T. D., Hunter, A., Sadeh, M., et al. (1998). Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology, 50, 1015–1020.
Chen, Y. Z., Hashemi, S. H., Anderson, S. K., Huang, Y., Moreira, M. C., Lynch, D. R., et al. (2006). Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiology of Disease, 23(1), 97–108.
Pierson, T. M., Adams, D., Bonn, F., Martinelli, P., Cherukuri, P. F., Teer, J. K., et al. (2011). Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genetics, 7(10), e1002325. doi:10.1371/journal.pgen.1002325. Epub 2011 Oct 13.
Lise, S., Clarkson, Y., Perkins, E., Kwasniewska, A., Sadighi Akha, E., et al. (2012). Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development. PLoS Genetics, 8(12), e1003074. doi:10.1371/journal.pgen.1003074. Epub 2012 Dec 6.
Lesage, S., Leutenegger, A. L., Ibanez, P., Janin, S., Lohmann, E., Dürr, A., et al. (2005). LRRK2 haplotype analyses in European and North African families with Parkinson disease: A common founder for the G2019S mutation dating from the 13th century. The American Journal of Human Genetics, 77(2), 330–332.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bower, M., Tuite, P. (2015). Overview of Movement Disorders. In: Goldman, J. (eds) Genetic Counseling for Adult Neurogenetic Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7482-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7482-2_1
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7481-5
Online ISBN: 978-1-4899-7482-2
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)